Ureteral Tumors

What is ureteral tumors?

Ureteral tumors are abnormal growths that form in the ureter, the thin muscular tube that carries urine from each kidney down to the bladder. Every person normally has two ureters, one on each side, and each is roughly 25 to 30 centimeters long. Because the ureters are narrow, even a small tumor can partly or completely block the flow of urine, which is one reason these growths can cause noticeable problems.

When people ask "what is ureteral tumors," they are usually asking about ureteral cancer. Most ureteral tumors are malignant (cancerous), and the great majority arise from the urothelium, the specialized lining that covers the inside of the kidney’s collecting system, the ureters, and the bladder. Cancer that starts in this lining is called urothelial carcinoma (formerly known as transitional cell carcinoma). When it occurs in the ureter or the renal pelvis, the funnel-shaped part of the kidney that collects urine, doctors group it under the term upper tract urothelial carcinoma. Less common types include squamous cell carcinoma and adenocarcinoma. Benign (non-cancerous) ureteral tumors, such as fibroepithelial polyps, do occur but are rare.

Ureteral tumors are uncommon compared with bladder cancer, even though both share the same lining and many of the same causes. They are diagnosed more often in older adults, typically after the age of 60, and more often in men than in women. People who have already been treated for bladder cancer have a higher chance of later developing a tumor in the ureter, so lifelong follow-up of the whole urinary tract is a standard part of care for that group.

Symptoms of ureteral tumors

Ureteral tumors symptoms can be subtle at first, and some people have no symptoms at all until the tumor is found during imaging done for another reason. When symptoms do appear, the most common ones include:

• Blood in the urine (hematuria), which may be visible as pink, red, or cola-colored urine, or may be detected only under a microscope during a urine test
• Pain in the side or back (flank pain), usually on one side, which may be dull and steady or come in waves
• Cramping pain similar to a kidney stone, caused by blood clots or the tumor itself blocking urine flow
• Frequent or urgent need to urinate, or a burning feeling when passing urine
• Unexplained fatigue or a general feeling of being unwell
• Unintended weight loss or loss of appetite, which tends to occur with more advanced disease
• Swelling of the kidney (hydronephrosis), which is not felt directly but is seen on imaging when urine backs up behind a blockage

Painless blood in the urine is the single most frequent sign, and it may come and go. Because it can disappear for weeks at a time, some people assume the problem has resolved. In many cases blood in the urine has a cause other than cancer, such as infection or stones, but it should always be evaluated.

Symptoms may differ by stage. Early, non-invasive tumors that are confined to the lining often cause only bleeding. Tumors that have grown into the muscle wall of the ureter or blocked it more completely are more likely to cause flank pain, kidney swelling, and reduced kidney function on that side. If cancer has spread beyond the ureter, symptoms may include bone pain, persistent cough, or a lump in the abdomen, depending on where it has traveled. Benign tumors, when they cause symptoms, usually produce blockage-type pain or intermittent bleeding rather than weight loss or fatigue.

Causes and risk factors

The exact ureteral tumors causes are not fully understood, but the disease develops when cells in the urothelial lining acquire genetic changes that allow them to grow out of control. Because the same lining runs from the kidney to the bladder, the substances and conditions that irritate or damage it anywhere along that path tend to raise the risk of cancer throughout the urinary tract.

Recognized risk factors include:

• Tobacco smoking. This is the most important avoidable risk factor. Chemicals absorbed from smoke are filtered by the kidneys and pass through the urine, where they come into prolonged contact with the ureteral lining. Risk rises with the amount and duration of smoking and falls slowly after quitting.
• Previous bladder cancer. People who have had urothelial cancer of the bladder have an increased chance of developing a tumor in the ureter or renal pelvis, sometimes years later.
• Occupational chemical exposure. Long-term exposure to certain industrial chemicals called aromatic amines, historically used in dye, rubber, leather, textile, and printing industries, is linked to urothelial cancer.
• Long-term use of certain pain relievers. Heavy, prolonged use of phenacetin-containing analgesics, now withdrawn in most countries, has been associated with upper tract urothelial cancer.
• Aristolochic acid. This substance, found in some traditional herbal remedies made from Aristolochia plants, damages the kidneys and is a known cause of urothelial cancer.
• Lynch syndrome. This inherited condition, best known for raising the risk of colon cancer, also increases the risk of upper tract urothelial tumors. A family history of colon, uterine, or urinary tract cancers at young ages may prompt genetic counseling.
• Chronic irritation or infection. Long-standing inflammation of the urinary tract, including from stones or repeated infections, may slightly increase risk, particularly for the rarer squamous cell type.
• Older age and male sex. Most cases occur in people over 60, and men are affected more often than women.

Having one or more of these risk factors does not mean a person will develop a ureteral tumor, and some people are diagnosed without any identifiable risk factor.

Diagnosis of ureteral tumors

Ureteral tumors diagnosis usually begins when a person reports blood in the urine or flank pain, or when an imaging scan done for another reason shows a blockage or a mass. Because the ureter is deep inside the body and cannot be examined directly by hand, doctors rely on a combination of urine tests, imaging, and direct inspection with a small camera. The evaluation is generally led by a urologist, a doctor who specializes in the urinary tract. At Acibadem, this evaluation is managed by the Urology department, often working alongside medical oncology and radiology.

Common steps include:

• Medical history and physical examination. Your doctor may ask about smoking, workplace exposures, previous bladder problems, family history, and the pattern of any bleeding or pain.
• Urinalysis. A basic urine test confirms whether blood is present and helps rule out infection.
• Urine cytology. A urine sample is examined under a microscope for abnormal cells shed from the lining of the urinary tract. A positive result raises suspicion, but a negative result does not rule out a tumor, especially a low-grade one.
• CT urography. A computed tomography (CT) scan performed with intravenous contrast dye that outlines the kidneys, ureters, and bladder. This is the preferred imaging test in most cases because it can show a filling defect (an area where dye does not flow), thickening of the ureter wall, or swelling of the kidney. It also helps assess whether nearby lymph nodes or other organs appear involved.
• MR urography. Magnetic resonance imaging may be used instead when a person cannot receive CT contrast because of kidney problems or allergy.
• Cystoscopy. A thin, flexible camera is passed through the urethra into the bladder to check for tumors there, because bladder and ureteral tumors often occur together.
• Ureteroscopy with biopsy. A very thin telescope is advanced from the bladder up into the ureter, allowing the doctor to see the tumor directly and take a small tissue sample (biopsy). Examination of this tissue by a pathologist confirms whether the growth is cancerous, what type it is, and its grade, meaning how abnormal the cells look and how quickly they are likely to grow.
• Blood tests. These assess overall kidney function, which matters both for diagnosis and for planning treatment.

Once a tumor is confirmed, doctors assign a stage, which describes how deeply the tumor has grown into or through the ureter wall and whether it has reached lymph nodes or distant organs. Staging is based on imaging and, when surgery is performed, on examination of the removed tissue. Additional scans of the chest or bones may be requested if there is concern about spread. Grade and stage together guide the choice of ureteral tumors treatment options.

Treatment options for ureteral tumors

Ureteral tumors treatment options depend on the type of tumor, its grade and stage, whether it is in one or both ureters, the function of both kidneys, and a person’s overall health and preferences. Treatment plans are usually developed by a team that includes a urologist, a medical oncologist (cancer drug specialist), a radiologist, and a pathologist.

Surveillance and observation. For very small, low-grade tumors that have been removed through a telescope, or for benign growths, your doctor may recommend close monitoring with regular ureteroscopy, urine tests, and imaging rather than immediate major surgery. Observation is also considered when a person is not well enough for an operation.

Kidney-sparing (endoscopic) procedures. Selected low-grade, small, non-invasive tumors may be treated through a ureteroscope using a laser or electrical energy to destroy or remove the growth while leaving the kidney and ureter in place. This approach preserves kidney function but carries a higher chance that the tumor will return, so lifelong follow-up with repeat ureteroscopy is required. It is often favored when a person has only one working kidney, reduced kidney function, or tumors on both sides.

Segmental ureterectomy. If a tumor is confined to a limited section of the ureter, particularly the lower portion near the bladder, the surgeon may remove only that segment and reconnect the healthy ends or reattach the ureter to the bladder. This preserves the kidney and is an option for some low-risk tumors.

Radical nephroureterectomy. This is the standard operation for high-grade or invasive ureteral cancer. The surgeon removes the affected kidney, the entire ureter on that side, and a small cuff of bladder where the ureter enters. The whole tract is removed because urothelial cancer tends to recur anywhere along the lining. Nearby lymph nodes may also be removed. The operation can be performed through open surgery or with minimally invasive laparoscopic or robot-assisted techniques, depending on the tumor and the surgeon’s assessment. Most people live well with one kidney, but kidney function is checked carefully before and after surgery.

Intravesical or intracavitary therapy. After endoscopic treatment, or after nephroureterectomy, medication may be instilled directly into the bladder or the upper tract to reduce the chance of recurrence. Drugs used this way include chemotherapy agents such as mitomycin and the immune-stimulating agent BCG. A single dose of chemotherapy placed in the bladder after nephroureterectomy is commonly recommended to lower the risk of a new bladder tumor.

Chemotherapy. Systemic chemotherapy, given by vein, may be offered before surgery (neoadjuvant) to shrink the tumor, or after surgery (adjuvant) when the cancer has invaded deeply or reached lymph nodes. It is also the main treatment when cancer has spread to distant organs. Cisplatin-based combinations are commonly used, but they require adequate kidney function, which is one reason chemotherapy is sometimes given before rather than after removal of a kidney.

Immunotherapy. Drugs called checkpoint inhibitors help the immune system recognize and attack cancer cells. They are used in certain settings for advanced urothelial cancer, and in some cases after surgery for high-risk disease. Eligibility depends on stage, prior treatment, and specific test results on the tumor tissue.

Radiation therapy. Radiation is not a primary treatment for most ureteral tumors, but it may be used to relieve symptoms such as pain or bleeding from cancer that has spread, or occasionally after surgery in specific situations.

Supportive care and rehabilitation. Managing pain, maintaining nutrition, and protecting the remaining kidney are part of treatment at every stage. After major surgery, a gradual return to activity, wound care, and monitoring of blood pressure and kidney function are typical. A person who has lost a kidney is generally advised to avoid medications that strain the kidneys and to stay well hydrated, though your doctor will tailor this advice.

Living with ureteral tumors and outlook

The outlook for a person with a ureteral tumor varies widely and depends most strongly on the grade and stage at diagnosis. Low-grade tumors confined to the lining are often controlled well, although they have a tendency to come back and require ongoing surveillance. High-grade tumors that have grown through the ureter wall or reached lymph nodes are more serious, and treatment aims to control the disease for as long as possible while maintaining quality of life. No doctor can promise a specific outcome, and statistics describe groups of people rather than any single individual.

Follow-up is a lifelong commitment for most people. Because urothelial cancer can appear elsewhere along the urinary lining, regular cystoscopy to check the bladder is standard for several years after treatment, along with periodic imaging of the remaining kidney and ureter and blood tests of kidney function. The schedule is usually more frequent in the first two years and then spaced out if no recurrence is found.

Practical adjustments help many people. Stopping smoking is the single most useful step to reduce the chance of new tumors and to protect general health. Keeping well hydrated, controlling blood pressure and diabetes, and reviewing all medications with a doctor or pharmacist help protect the remaining kidney. Emotional support matters too; a diagnosis that requires years of monitoring can be stressful, and talking with a counselor, support group, or trusted clinician is a reasonable part of care.

Frequently asked questions

What is ureteral tumors, in simple terms?

A ureteral tumor is an abnormal growth inside the ureter, the tube that carries urine from a kidney to the bladder. Most of these growths are a form of cancer called urothelial carcinoma, which starts in the lining of the urinary tract. Benign ureteral tumors exist but are rare. Because the tube is narrow, tumors often cause blood in the urine or block urine flow.

What are the first ureteral tumors symptoms people notice?

The most common first sign is blood in the urine, which may be visible or found only on a urine test, and it often occurs without pain. Some people notice one-sided flank or back pain, sometimes cramping like a kidney stone. Others have no symptoms, and the tumor is found on a scan done for another reason. Any blood in the urine should be evaluated even if it stops on its own.

What are the main ureteral tumors causes?

There is no single cause, but tobacco smoking is the strongest known risk factor because smoke chemicals concentrate in urine and irritate the lining. Other contributors include a history of bladder cancer, workplace exposure to certain industrial chemicals, some herbal products containing aristolochic acid, long-term use of certain older painkillers, and an inherited condition called Lynch syndrome. Many people diagnosed have no clear cause.

How is ureteral tumors diagnosis confirmed?

Doctors usually combine a urine test for blood and abnormal cells, a CT urogram to picture the kidneys and ureters, and cystoscopy to check the bladder. If a suspicious area is seen, a ureteroscopy allows a small camera to view the tumor directly and take a biopsy. Examination of that tissue under a microscope is what confirms the diagnosis and shows the tumor’s type and grade.

What are the standard ureteral tumors treatment options?

Options range from close monitoring and telescope-based laser removal for small, low-grade tumors, to removal of a segment of ureter, to radical nephroureterectomy, which removes the kidney, ureter, and part of the bladder for high-grade or invasive cancer. Medication placed in the bladder, intravenous chemotherapy, and immunotherapy may be added depending on stage. The plan is individualized to the tumor and to the person’s kidney function and general health.

Can you live a normal life with one kidney after surgery?

Many people live full lives with a single healthy kidney. The remaining kidney typically adapts to handle the workload, although overall kidney function is somewhat lower than with two. Doctors generally advise staying hydrated, controlling blood pressure, avoiding medications that can harm the kidneys, and attending regular blood tests. Your care team will explain any specific precautions based on your situation.

Do ureteral tumors come back after treatment?

Recurrence is a recognized feature of urothelial cancer because the same type of lining extends through the whole urinary tract. Tumors can return in the bladder or, less often, in the opposite ureter or kidney, sometimes years later. This is why lifelong follow-up with cystoscopy, imaging, and urine tests is recommended. Catching a recurrence early usually allows simpler treatment.

When to see a doctor

Blood in the urine is never considered normal and should always be checked by a doctor, even if it happens only once or goes away on its own. Persistent one-sided flank or back pain that has no clear explanation also deserves evaluation, especially in people over 60 or those who smoke or have had bladder cancer. Early assessment gives the best chance of identifying a treatable cause, whether that turns out to be an infection, a stone, or a tumor.

Seek urgent medical attention if you experience any of the following red-flag signs:

• Heavy bleeding in the urine, passing large blood clots, or urine that is dark red
• Inability to pass urine or a sudden, marked drop in the amount of urine
• Severe flank or abdominal pain that does not ease with rest or usual pain relief
• Fever, chills, or shaking along with urinary symptoms or back pain, which may indicate a serious infection behind a blocked kidney
• Nausea and vomiting with an inability to keep fluids down
• Confusion, extreme drowsiness, or fainting
• New swelling of the legs, shortness of breath, or sudden severe bone pain in a person already diagnosed with a ureteral tumor

People who are already under treatment or surveillance for a ureteral tumor should also report new or returning symptoms promptly to their care team rather than waiting for the next scheduled visit.